Medical Devices Acquisitions in Pennsylvania

Surmodics has completed a merger with Biocoat and formed a new division, Surmodics Services & Technologies (SST), to carry forward the portion of Biocoat's business remaining after divesting certain assets. SST, based in Horsham, Pennsylvania, will provide hydrophilic coating technologies, custom polymer formulations and full-service coating operations to medical device manufacturers worldwide.

Allegheny Performance Plastics has acquired Holbrook Tool and Molding, Inc., a precision injection molding and tooling company based in Meadville, Pennsylvania. The transaction expands Allegheny’s medical molding and tooling capabilities, adding tight-tolerance mold building and insert molding expertise for medical manufacturing.

Resonetics has acquired Eden Holdings (comprising Eden Manufacturing and Eden Tool), adding precision micro-molding, insert-molding, and advanced machining and tooling to its MedTech manufacturing capabilities. The deal expands Resonetics' polymer and tooling capabilities to better serve medical device OEM end markets including robotic surgery, minimally invasive surgery, electrophysiology, and rapid diagnostics.

Premier Biotech, a portfolio company of Align Capital Partners, acquired certain assets comprising OraSure Technologies' substance abuse testing business line and the Mexican subsidiary of Green Earth Biomedical LLC (GEM). The transactions expand Premier's oral-fluid toxicology product portfolio and accelerate its international distribution footprint in Mexico and Latin America.

Montagu Private Equity has acquired Tyber Medical, LLC and combined it with its existing portfolio companies Resolve Surgical Technologies and Intech to form an integrated medical device solutions provider. The transaction, which closed on April 8, 2025, creates a next-generation, global orthopedic device development and manufacturing platform offering private-label implantable devices, instrumentation, design, regulatory and advanced manufacturing capabilities.

Radial Equity Partners has partnered with Premier Dental Products Company, a fourth-generation, family-owned developer and manufacturer of dental consumables based in Plymouth Meeting, Pennsylvania. Perry Lowe will become CEO as part of the transaction, which aims to accelerate Premier's product innovation and commercial expansion; terms were not disclosed.

PROTEOR has acquired Filament Innovations, a U.S.-based maker of high-speed FDM/FGF 3D printers and specialty filaments for the orthotics & prosthetics industry. The acquisition strengthens PROTEOR's digital solutions portfolio by adding 3D printing hardware and materials capabilities to its scanning and rectification software offerings.

AA Medical, a supplier of refurbished medical equipment, has acquired Surgical Product Solutions (SPS), a provider of in‑date surgical consumables and supplies, for an undisclosed amount. The acquisition expands AA Medical's product portfolio to include SPS's surgical consumables, strengthening its position as a comprehensive third‑party provider to hospitals, health systems and other care sites and improving accessibility and affordability of premium medical products.

Integer Holdings Corporation has acquired Pulse Technologies, a Quakertown, Pennsylvania-based contract manufacturer of complex micro-machined medical device components, for approximately $140 million. The acquisition expands Integer's end-to-end development capabilities and manufacturing footprint in high-growth structural heart, neuromodulation and electrophysiology markets and brings roughly 250 Pulse employees into Integer.

Nevro Corp. acquired Vyrsa Technologies, a privately held medical technology company focused on minimally invasive sacroiliac (SI) joint fusion devices, in a deal that closed November 30, 2023. Nevro paid $40 million at closing and may pay up to an additional $35 million in cash or stock tied to development and sales milestones; the company said Vyrsa will broaden its product portfolio and is projected to be accretive in 2024.

Silony Medical International AG completed the acquisition of Centinel Spine’s Global Fusion Business, including all cervical and lumbar fusion products and the STALIF technology platform. The deal gives Silony a major entry into the United States market, strengthens its anterior standalone cage offering, and the company will rebrand to Silony Spine to emphasize its focus on spinal fusion technology.

Inverness Graham, a Philadelphia-based private equity firm, has acquired Azer Scientific, a Morgantown, Pennsylvania provider of laboratory consumables and equipment. Azer will be combined with Inverness Graham portfolio company Electron Microscopy Sciences (EMS) to create a scaled life sciences and clinical diagnostics platform; terms were not disclosed.

GTCR has made a strategic, majority recapitalization investment in Biocoat Holdings, LLC, a Horsham, Pennsylvania-based provider of biocompatible hydrophilic coatings and dip-coating equipment for medical devices. Existing investor 1315 Capital and Biocoat management retain minority stakes; GTCR will partner with CEO Jim Moran and add industry veteran Chip Hance as Executive Chairman to support growth, capability expansion and follow-on acquisitions.

CIVCO Radiotherapy announced it is joining forces with Qfix, a maker of patient positioning and immobilization devices for radiotherapy. The integration is intended to combine product portfolios, manufacturing capabilities and R&D to accelerate innovation, improve customer service and deliver enhanced radiotherapy products.

Tivic Health Systems, Inc. (Nasdaq: TIVC) entered a definitive agreement to acquire the Reliefband product line and related assets from Reliefband Technologies, LLC for up to $33.5 million (with up to $1.5 million payable in Tivic restricted common stock). The deal adds FDA-cleared, wearable electronic therapeutics to Tivic’s direct-to-consumer and prescription product portfolio to accelerate revenue growth and expand its bioelectronic medicine offerings.

LumiThera, through a wholly owned subsidiary, purchased the assets of MacuLogix, including the AdaptDx Pro dark adaptometer used for early diagnosis of dry age-related macular degeneration (AMD). The acquisition expands LumiThera's diagnostic and monitoring capabilities and complements its Valeda photobiomodulation treatment platform for dry AMD patients.

Burlington Medical, a portfolio company of Peninsula Capital Partners, has acquired Lite Tech, Inc. (d/b/a XenoLite), a Norristown, Pennsylvania manufacturer of lightweight, lead-free radiation-protective aprons and related products. The deal is an add-on to the Burlington platform and expands its manufacturing capabilities and product offering in the healthcare radiation-protection market, creating what Burlington describes as the world's largest manufacturer of radiation-protective aprons.

Laborie Medical Technologies has completed the acquisition of GI Supply, a specialist maker of endoscopy and paracentesis products. GI Supply and its employees will be fully integrated into Laborie to expand the company's gastroenterology product portfolio and commercial capabilities; the deal is supported by Laborie's majority owner Patricia Industries and growth-equity partner Signet Healthcare Partners.

Royal Philips has signed an agreement to acquire Vesper Medical Inc., a US-based maker of minimally-invasive peripheral venous stent devices and a portfolio company of Gilde Healthcare. The acquisition will add Vesper's DUO Venous Stent System to Philips' image-guided therapy and peripheral vascular portfolio; the deal is expected to close in Q1 2022 and includes roughly 20 Vesper employees joining Philips.

LumiThera, a commercial-stage ophthalmic medical device company, entered a definitive merger agreement to acquire Diopsys in a stock-for-stock transaction under which Diopsys will become a wholly owned subsidiary of LumiThera. The deal combines Diopsys' visual electrophysiology diagnostic systems with LumiThera's photobiomodulation treatment platform to create a coordinated light-based theranostic approach for diagnosing, treating and monitoring ocular disease.

ARCH Medical Solutions (part of ARCH Global Precision) has acquired three precision machining subsidiaries of VfD Technologies: Wilsey Tool Company, Isimac Manufacturing Company and Choice Precision. The businesses—specializing in precision contract manufacturing for medical devices and machining robotic end-effectors—will operate collectively as ARCH Medical Solutions – Lehigh Valley to expand ARCH's capabilities and capacity in the medical products and automation markets.

Chicago-based Linden Capital Partners completed a majority investment in RQM+ (headquartered in Monroeville, Pennsylvania), partnering with the company’s founders and management to accelerate growth and expand regulatory, quality, and compliance services for medical device and IVD manufacturers. The transaction represents a sale by prior investors DFW Capital Partners and Chartwell/Chief Capital and will support organic growth and acquisitions to broaden RQM+’s service offerings.

Kymanox Corporation, a life-sciences-focused professional services firm, has acquired Neuma LLC, an engineering services provider specializing in drug delivery devices and combination products. The deal — funded by a recent growth recapitalization from WestView Capital Partners — expands Kymanox's product development and combination-product capabilities to better support clients across biopharma and medical device markets.

Inverness Graham Investments has acquired Electron Microscopy Sciences (EMS), a Hatfield, Pennsylvania-based manufacturer and distributor of microscopy, histology and sample-prep reagents, consumables and equipment. The transaction represents Inverness Graham’s first investment to build a broader life sciences manufacturing and distribution platform, with plans to invest in product development, operations, and pursue complementary add-on acquisitions.

Therabody (formerly Theragun) has acquired RP Sports, the maker of the clinical pneumatic compression product line RecoveryPump, and will integrate the technology into its recovery and whole-body wellness portfolio. The acquisition brings FDA‑approved medical-grade compression devices to Therabody's consumer channel and supports the launch of the Therabody Recovery Lounge to offer integrated recovery solutions to teams, facilities, and consumers.

Regulatory and Quality Solutions LLC (R&Q) acquired Maetrics LLC on September 10, 2020 to create an enlarged global regulatory and quality consultancy focused on medical devices, diagnostics, and pharmaceuticals. The combination brings together R&Q's regulatory services with Maetrics' international footprint and expertise to form the largest medical device–focused regulatory and quality consultancy.

Royal Philips has signed an agreement to acquire Intact Vascular, a U.S.-based developer of the Tack Endovascular System, to expand Philips' image-guided therapy devices portfolio for peripheral artery disease. The deal includes USD 275 million upfront in cash plus deferred payments (up to ~USD 360 million total) and is expected to close in the third quarter of 2020, after which Intact Vascular will join Philips' Image-Guided Therapy business.

Riverside Insights, a portfolio company of Alpine Investors, acquired ImPACT Applications, a provider of FDA-cleared neurocognitive concussion assessment tools. ImPACT will continue to operate under its brand with Mike Wahlster remaining as leader; the deal expands Riverside's assessment offerings across education, healthcare, and sports markets.

Etac, a wholly-owned subsidiary of Swedish investor Nordstjernan, has acquired 70% of HoverTech International, a US leader in air-assisted patient handling systems based in Allentown, Pennsylvania. The majority investment strengthens Etac's position in patient handling/medtech, creates a platform for accelerated growth and cross‑selling in the US and other export markets, and brings HoverTech access to Etac's global sales and R&D resources.

Philadelphia-based healthcare investment firm 1315 Capital has acquired Biocoat, Inc., a Horsham, Pennsylvania specialty manufacturer of hydrophilic biomaterial coatings for medical devices; the transaction closed on December 20, 2018. 1315 Capital's investment will provide expansion and growth capital to accelerate R&D, expand Biocoat's operating model, and support broader commercial efforts across neurovascular, cardiovascular, peripheral, and ophthalmic end markets.

OraSure Technologies agreed to acquire two companies—CoreBiome, a Minnesota-based microbiome services provider, and Novosanis, a Belgian urine-collection device maker—to expand its Molecular business. The deals (upfront plus potential performance-based payments) will add microbiome sequencing/bioinformatics and urine first-void collection capabilities to OraSure's specimen collection and molecular diagnostics portfolio.

TouchPoint has acquired the Health Care Technology business of InterMetro Industries and formed a new platform, TouchPoint Medical, that combines the acquired product lines with TouchPoint's existing medical technology businesses. The acquisition expands TouchPoint Medical's offerings to include mobile computing workstations, automated medication dispensing equipment and mounting systems for hospitals, long-term care and other healthcare facilities.